Arcutis Reports Q1 2026 Earnings with Strong Revenue Growth and Positive Cash Flow
Arcutis (ARQT) reported Q1 2026 earnings with net product revenue of $105.4 million, a 65% increase year-over-year, driven by higher patient demand and improved gross-to-net rates. The company achieved positive operating cash flow of $2.2 million and maintained its full-year revenue guidance between $480 million and $495 million.
Tickers: $ARQT
Topics: cash flow guidance prescription trends revenue sales force expansion